Nls Pharmaceutics Ltd (NLSP) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Nls Pharmaceutics Ltd  (NASDAQ: NLSP)

Nls Pharmaceutics Ltd Profitability Comparisons

Select each Category to receive further Information




NLSP Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q4 MRQ) - 74.4 % 71.51 % 55 %
Gross Margin (Q4 TTM) - 74.64 % 68.43 % 49.45 %
Gross Profit Margin 5 Yr. Avg. - 66.05 % 64.67 % 47.07 %
EBITDA Margin (Q4 MRQ) - 25.35 % 22.34 % 23.52 %
EBITDA Margin (Q4 TTM) - 21.17 % 19.14 % 20.29 %
EBITDA Margin 5 Yr. Avg. - 45.98 % 31.17 % 22.06 %
Operating Margin (Q4 MRQ) - 22.51 % 19.09 % 20.91 %
Operating Margin (Q4 TTM) - 17.48 % 15.76 % 17.74 %
Operating Margin 5 Yr. Avg. - 15.55 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q4 MRQ) - 19.18 % 15.05 % 12.22 %
Pre-Tax Profit Margin (Q4 TTM) - 15.72 % 13 % 12.45 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.09 % 10.45 % 12.49 %
Net Margin (Q4 MRQ) - 16.94 % 13 % 10.12 %
Net Margin (Q4 TTM) - 20.63 % 15 % 10.36 %
Net Margin 5 Yr. Avg. - 6.22 % 6.23 % 9.95 %